The second quarter of 2018 was another robust one for healthcare deal-making, according to a new report from PwC. The group’s Thad Kresho tells FierceHealthcare that private equity’s interest in the industry will be a trend to watch.
The second quarter of 2018 was another robust one for healthcare deal-making, according to a new report from PwC. The group’s Thad Kresho tells FierceHealthcare that private equity’s interest in the industry will be a trend to watch.